Living donor liver transplantation in patients weighing ≥100 kg: Low graft weight and obesity do not impact outcomes

Shaleen Agarwal, Neerav Goyal, Mohammed Nayeem, Shishir Pareek, Subash Gupta – 12 October 2016 – Living donor liver transplantation (LDLT) in obese patients raises concerns with regards to obtaining grafts of “adequate” graft‐to‐recipient weight ratio (GRWR) and the impact of obesity on the outcomes of LDLT. LDLT outcomes in patients weighing ≥100 kg were compared with those weighing <100 kg. Patients weighing ≥100 kg were divided into 3 categories based on the GRWR of the grafts they received.

LiverLearning®: 2016 Webinar: New Concepts and Insights Into HBV Immunology

This webinar will review the current state of the understanding of the immune response to hepatitis b (HBV). Two experts and one moderator will guide providers through an understanding of the HBV immune interactions that can help providers understand and help explain HBV infections, guide patient management and help embrace new therapies.Rachel Church (Moderator) Rachel Church, PhD is a Research Assistant Professor in the Department of Pharmacotherapy and Experimental Therapeutics within the Eshelman School of Pharmacy at the University of North Carolina, Chapel Hill.

LiverLearning®: 2016 Webinar: Management of Bleeding Fundal and Ectopic Varices – TIPS, BRTO, and Embolization

The evidence to support therapeutic decisions in patients with cirrhosis and fundal and ectopic varices is scarce, and treatment is controversial. In addition, since these varices are infrequent, clinicians have limited experience and knowledge of the therapeutic options.

De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S‐transferase theta 1

Luis Ibáñez‐Samaniego, Magdalena Salcedo, Javier Vaquero, Rafael Bañares – 6 October 2016 – De novo autoimmune hepatitis (DAIH) is a rare clinical condition with features that resemble those of autoimmune hepatitis (AIH) in patients undergoing liver transplantation (LT) for nonautoimmune liver disease. The diagnosis of this entity has been based on the presence of biochemical and histological patterns similar to those observed in the primary AIH, although several considerations must be taken into account.

Subscribe to